Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib

Eri Banno, Yosuke Togashi, Marco A. De Velasco, Takuro Mizukami, Yu Nakamura, Masato Terashima, Kazuko Sakai, Yoshihiko Fujita, Ken Kamata, Masayuki Kitano, Masatoshi Kudo, Kazuto Nishio

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences